Understanding the physics of the immune response necessitates new technology
Professor Marco Fritzsche has been jointly funded by the Kennedy Trust and the Rosalind Franklin Institute to join the Kennedy Institute as the Principal Investigator of the Biophysical Immunology Laboratory (BPI). His lab is leading the development of a lattice...
CD2 corolla calls T cells to arms
A study led by Professor Mike Dustin’s group at the Kennedy Institute has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. Read more here....
New insight into the causes of rheumatoid arthritis
Professor Chris Buckley and Dr Adam Croft at the University of Birmingham’s Rheumatology Research Group have identified the chemical messenger which instructs cells to destroy joints, leading to hope for new treatments. Read the full article here....
PhD student’s research review reveals potential to improve colon cancer treatments
Kennedy Trust’s PhD student Alina Janney at the Kennedy Institute for Rheumatology Research has published a paper in Nature reviewing the role of the microbiome in colorectal cancer. Read more...
Oxford researchers start new trial on the use of anti-TNF to treat COVID-19 in care homes
We are hopeful that anti-TNF therapy, first identified by Professor Sir Marc Feldmann and the Trust’s President Professor Sir Ravinder Maini, might prove to be an effective treatment for patients with COVID-19. Read the full article here....